drugset / Trial / NCT00682734

Metoclopramide for Migraine: A Dose Finding Study

NCT00682734

Phase 3 Completed 349 enrolled Montefiore Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Metoclopramide is an effective intravenous treatment for acute migraine attacks, but we do not know the best dose to administer. This study compares three different doses of metoclorpamide.

Timeline

Start
2008-04
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoclopramide Small molecule 10 mg Intravenous
Comparator Metoclopramide Small molecule 20 mg Intravenous
Comparator Metoclopramide Small molecule 40 mg Intravenous
Background Diphenhydramine Unknown 25 mg Intravenous

Indications